Bastos, Jasílio Vilela <br/><br/>
Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and -10.  [electronic resource] 

 -  Archives of oral biology  Jun 2011 
 - 540-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1506 
<br/><br/><label>Standard No.: </label>10.1016/j.archoralbio.2010.11.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer--pharmacology<br/>Alveolar Bone Loss--prevention & control<br/>Analysis of Variance<br/>Animals<br/>Disease Models, Animal<br/>Interleukin-10--agonists<br/>Interleukin-6--antagonists & inhibitors<br/>Interleukin-8--antagonists & inhibitors<br/>Male<br/>Osteoclasts--drug effects<br/>Peroxidase--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Opioid, kappa--agonists<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors